AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Rcnet 12.5 Capsule

Prescription Icon
Prescription Required

Marketer

BDR Pharmaceuticals Internationals Pvt

Salt Composition

Sunitinib (12.5mg)

Overview Rcnet 12.5 Capsule

Axumin 12.5mg capsules treat kidney cancer and gastrointestinal stromal tumors by inhibiting enzymes crucial for cancer cell proliferation. This action reduces tumor size and growth rate. Axumin 12.5mg capsules may be taken with or without food, but consistent daily timing maximizes effectiveness. Dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's prescription; incorrect usage or overdose can lead to severe adverse effects. Benefits may take weeks or months to appear; discontinue only as directed by your doctor. Common side effects include fatigue, diarrhea, nausea, vomiting, altered taste, and reduced appetite. Your doctor may recommend regular blood pressure and thyroid function monitoring. It can lower blood glucose, potentially causing fainting; diabetics should monitor their blood sugar closely and discuss potential adjustments to their diabetes medication. Inform your doctor of any pre-existing heart, liver, kidney, or bleeding disorders before starting treatment. Inform your healthcare provider of all medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is essential for both partners throughout treatment.

Uses of Rcnet 12.5 Capsule

Managing Renal Cell Carcinoma and Gastrointestinal Stromal Tumors

Major Benefits of Rcnet 12.5 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Rcnet 12.5 Capsules can be consumed with or without food, although consistent timing is preferable.

Common Side effects of Rcnet 12.5 Capsule:

  • Hand-foot syndrome
  • Bleeding disorder
  • Low blood platelets
  • Decreased appetite
  • Nausea
  • Vomiting
  • Weakness
  • Abdominal pain
  • Indigestion
  • High blood pressure
  • Diarrhea
  • Stomatitis (Inflammation of the mouth)
  • Taste change

How to use Rcnet 12.5 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Rcnet 12.5 Capsules can be ingested with or without food, however, consistent daily timing is recommended.

How Rcnet 12.5 Capsule works:

Rcnet 12.5 Capsule combats cancer by targeting tyrosine kinase, a protein on the surface of cancer cells. This targeted binding inhibits the protein's activity, halting cancer cell growth and propagation. Additionally, the drug restricts the development of tumor blood vessels, further limiting cancer spread and proliferation.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Rcnet 12.5 Capsule lacks established safety data. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Rcnet 12.5 Capsule during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Rcnet 12.5 Capsule while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Rcnet 12.5 Capsules might lead to side effects that impair driving ability. Dizziness is a possible side effect. Refrain from driving or operating machinery if dizziness occurs during treatment.

KidneyKidneySAFE IF PRESCRIBED

Rcnet 12.5 Capsule presents no need for dosage modification in individuals with renal impairment and is considered safe for their use.

LiverLiverSAFE IF PRESCRIBED

Rcnet 12.5 Capsule poses no safety concerns for patients with hepatic impairment; no dosage modification is necessary.

What if you forget to take Rcnet 12.5 Capsule :

Omit any missed Rcnet 12.5 Capsule dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Rcnet 12.5 Capsule

LabelValue
Type of Compound Compounds derived from indole and pyrrole.
Potential for Dependence None.
Type of Treatment Cancer-fighting drugs

FAQs on Rcnet 12.5 Capsule

Follow your doctor's instructions precisely when using Rcnet 12.5 Capsules. Only oncologists experienced in cancer treatment should initiate this medication. Administer once daily, with or without food. Avoid grapefruit juice and grapefruit while taking Rcnet 12.5 Capsules to minimize potential adverse reactions.
Rcnet 12.5 Capsule treatment may result in skin lightening and hair loss. Patients might also develop dry, thickened, or cracked skin, blisters, or rashes on their hands and feet. These reactions typically resolve upon discontinuation of the medication. However, serious, potentially fatal skin reactions, including severe rashes or rapidly progressing skin sores, are possible. Report any signs of infection near a skin wound, such as fever, pain, redness, swelling, or pus/blood discharge, to your physician immediately.
Rcnet 12.5 Capsule carries a risk of severe hepatic complications, potentially fatal. Report immediately to your physician any symptoms like jaundice (yellowing of eyes or skin), dark urine, or upper right abdominal pain or discomfort. Pre- and ongoing liver function monitoring through blood tests will be conducted by your doctor. Should liver problems arise, your doctor might suspend or discontinue Rcnet 12.5 Capsule treatment.
Rcnet 12.5 Capsule currently lacks generic alternatives. Its mechanism of action involves inhibiting a protein kinase enzyme, a molecule found on the surface of cancerous cells that drives their proliferation and metastasis. This enzyme blockade prevents further cancer spread. Other medications that similarly target protein kinases include erlotinib, gefitinib, lapatinib, vemurafenib, and dasatinib.
No research validates combining Rcnet 12.5 Capsules with other chemotherapeutic agents. Specifically, Rcnet 12.5 Capsules treat gastrointestinal stromal tumors (GIST), a stomach and bowel cancer, when imatinib, an alternative cancer medication, proves ineffective or is unsuitable for the patient.
Indeed, Rcnet 12.5 Capsules can lower blood glucose. Consequently, diabetic patients should exercise heightened caution, as hypoglycemia may lead to loss of consciousness. Regular blood glucose monitoring is crucial; adjustments to anti-diabetic medication dosage may be necessary depending on the results.
Rcnet 12.5 Capsule commonly elevates blood pressure. Consequently, consistent blood pressure monitoring is crucial. Report any significant headache, dizziness, lightheadedness, or visual disturbances to your physician. They may prescribe antihypertensive medication or temporarily suspend treatment until your blood pressure normalizes.
Rcnet 12.5 Capsule
406
MRP 495
17% off